The AmpSure® HPV 16/18 Genotype Assay is an in vitro diagnostic test for detecting and genotyping human papillomavirus (HPV) types 16 and 18 in clinical specimens. This molecular assay enables precise identification of high-risk HPV strains associated with cervical cancer and related malignancies, s...
Manufactured by
shanghai rendu biotechnology co.,ltd.
China
Shanghai Rendu Biotechnology, founded in 2007, is a high-tech enterprise pioneering second-generation molecular diagnostic technology in China. The company develops and manufactures IVD reagents and fully automated instruments for prenatal screening, hand-foot-mouth disease, respiratory pathogens, food safety, and blood testing. ISO13485 certified with 13 registered IVD reagent products and 3 instrument products, serving over 400 medical institutions (70% tertiary hospitals).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
SeeGene Middle East FZE
South Korea · 4 relevant products
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 10 relevant products
54 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 113 closest product alternatives
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for detecting and genotyping high-risk human papillomavirus strains. Supports cervical cancer screening and risk stratification.
SeeGene Middle East FZE · South Korea
The Allplex HPV28 Assay is a real-time PCR-based diagnostic test that simultaneously detects 28 human papillomavirus (HPV) types for cervical cancer screening and risk stratification. This high-multiplex assay integrates seamlessly into automated laboratory workflows, enabling rapid syndromic detection with comprehensive HPV genotyping in a single reaction.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
HPV genotyping assay detecting 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82 high-risk variants for comprehensive cervical cancer risk assessment.
110 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products